YD Bio (YDES) director files Form 3 with no share activity

Rhea-AI Filing Summary

YD Bio Ltd director Lee Jerry Yin-Chia has filed a Form 3 insider report for YDES. The filing lists him as a director and indicates no reported purchases, sales, or other insider transactions, with all transaction counts and share totals recorded as zero.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lee Jerry Yin-Chia

(Last) (First) (Middle)

C/O YD BIO LIMITED

12F., NO. 3, XINGNAN ST., NANGANG DIST.

(Street)

TAIPEI CITY 115001

(City) (State) (Zip)

TAIWAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
YD Bio Ltd [ YDES ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Jerry Yin-Chia Lee	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does YD Bio (YDES) disclose in this Form 3 filing?

The filing shows a Form 3 insider report for YD Bio Ltd identified by ticker YDES. It records director Lee Jerry Yin-Chia as the reporting person and shows no insider transactions or holdings data beyond zero share activity.

Who is the reporting person in YD Bio (YDES) Form 3?

The reporting person is Lee Jerry Yin-Chia, listed with the role of director of YD Bio Ltd. He is not marked as an officer or a ten percent owner in this Form 3 insider data set for ticker YDES.

Does the YD Bio (YDES) Form 3 show any insider share purchases?

No insider purchases are shown. The transaction summary in the Form 3 data reports buyCount of 0 and buyShares of 0, indicating no recorded open-market or other purchase transactions for YD Bio Ltd shares by the reporting person.

Are there any insider sales reported for YD Bio (YDES) in this Form 3?

No. The Form 3 transaction summary lists sellCount and sellShares as 0. It also shows netBuySellDirection as "neutral," indicating no net buying or selling activity recorded for the reporting person in this filing.

Does the YD Bio (YDES) Form 3 include derivative securities activity?

The Form 3 data shows no derivative activity. derivativeTransactionCount and exerciseCount are both 0, and the derivativeSummary is empty, indicating no options, warrants, or similar derivative insider transactions are reported in this filing.